UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut−Brain Interaction): A Rome Foundation Working Team Report

Gastroenterology (New York, N.Y. 1943), 2018-03, Vol.154 (4), p.1140-1171.e1

2018

Volltextzugriff (PDF)

Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators

Journal of the American Chemical Society, 2016-06, Vol.138 (21), p.6754-6764

2016

Volltextzugriff (PDF)

Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation

Nature (London), 2016-07, Vol.535 (7612), p.448-452

2016

Volltextzugriff (PDF)

Cannabinoid Receptors: Where They are and What They do

Journal of neuroendocrinology, 2008-05, Vol.20 (s1), p.10-14

Mackie, K.

2008

Volltextzugriff (PDF)

Molecular insights into the biased signaling mechanism of the μ-opioid receptor

Molecular cell, 2021-10, Vol.81 (20), p.4165-4175.e6

2021

Volltextzugriff (PDF)

An engineered IL-2 partial agonist promotes CD8+ T cell stemness

Nature (London), 2021-09, Vol.597 (7877), p.544-548

2021

Volltextzugriff (PDF)

High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875

Nature (London), 2014-09, Vol.513 (7516), p.124-127

2014

Volltextzugriff (PDF)

X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors

Nature (London), 2014-08, Vol.512 (7514), p.333-337

2014

Volltextzugriff (PDF)

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor

Nature (London), 2011-01, Vol.469 (7329), p.241

2011

Volltextzugriff (PDF)

EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors

Neuropharmacology, 2012-02, Vol.62 (2), p.1099-1110

2012

Volltextzugriff (PDF)

Conformational dynamics of a class C G-protein-coupled receptor

Nature (London), 2015-08, Vol.524 (7566), p.497-501

2015

Volltextzugriff (PDF)

Current drug treatments targeting dopamine D3 receptor

Pharmacology & therapeutics (Oxford), 2016-09, Vol.165, p.164-177

2016

Volltextzugriff (PDF)

Structure of the IFNγ receptor complex guides design of biased agonists

Nature (London), 2019-03, Vol.567 (7746), p.56-60

2019

Volltextzugriff (PDF)

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

Journal of medicinal chemistry, 2011-05, Vol.54 (9), p.3206-3221

2011

Volltextzugriff (PDF)

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

Psychopharmacology, 2016-10, Vol.233 (19-20), p.3503-3512

2016

Volltextzugriff (PDF)

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

British journal of pharmacology, 2016-01, Vol.173 (1), p.27-38

2016

Volltextzugriff (PDF)

Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro

Toxicology (Amsterdam), 2022-01, Vol.465, p.153024-153024, Article 153024

2022

Volltextzugriff (PDF)

Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior

The Journal of neuroscience, 2010-02, Vol.30 (6), p.2115-2129

2010

Volltextzugriff (PDF)

Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Current pharmaceutical design, 2010-02, Vol.16 (5), p.488-501

2010

Volltextzugriff (PDF)

The Role of Dopamine D 3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens

The Journal of pharmacology and experimental therapeutics, 2019-11, Vol.371 (2), p.517-525

2019

Volltextzugriff (PDF)

The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats

Neuropharmacology, 2017-11, Vol.126, p.190-199

2017

Volltextzugriff (PDF)

Pharmacological Properties of δ -Opioid Receptor-Mediated Behaviors: Agonist Efficacy and Receptor Reserve

The Journal of pharmacology and experimental therapeutics, 2020-08, Vol.374 (2), p.319-330

2020

Volltextzugriff (PDF)

Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis

Trends in pharmacological sciences (Regular ed.), 2010-12, Vol.31 (12), p.580-586

2010

Volltextzugriff (PDF)

Molecular Interaction Between Butorphanol and κ-Opioid Receptor

Anesthesia and analgesia, 2020-09, Vol.131 (3), p.935-942

2020

Volltextzugriff (PDF)

A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome

The Journal of neuroscience, 2012-02, Vol.32 (5), p.1803-1810

2012

Volltextzugriff (PDF)

1 – 25 von 408

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(326)

Publikationsform

Artikel
(405)
Buchkapitel
(3)

Sprache

Englisch
(407)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut−Brain Interaction): A Rome Foundation Working Team Report

Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators

Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation

Cannabinoid Receptors: Where They are and What They do

Molecular insights into the biased signaling mechanism of the μ-opioid receptor

An engineered IL-2 partial agonist promotes CD8+ T cell stemness

High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875

X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor

EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors

Conformational dynamics of a class C G-protein-coupled receptor

Current drug treatments targeting dopamine D3 receptor

Structure of the IFNγ receptor complex guides design of biased agonists

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro

Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior

Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

The Role of Dopamine D 3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens

The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats

Pharmacological Properties of δ -Opioid Receptor-Mediated Behaviors: Agonist Efficacy and Receptor Reserve

Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis

Molecular Interaction Between Butorphanol and κ-Opioid Receptor

A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome

Suchergebnisse filtern